Speaker: 

Richard Sofoluke, MD Residents, Geisinger - has nothing to disclose.

Moderator: 

Benjamin Hale, MD, Resident, Geisinger - has nothing to disclose. 

Learning Objectives:  

At the conclusion of this session, the participant should be able to:

  • Discuss pathogenesis in development of UGH Syndrome
  • Discuss preventative options regarding UGH syndrome
  • Discuss treatment options regarding UGH Syndrome

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Herbert Ingraham, MD, Benjamin Hale, MD, Gregory Notz, DO, Michael Higgins, OD, Laura Miller, PA-C and Jessica Yancoskie, CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.

Session date: 
08/23/2024 - 7:30am to 8:30am EDT
Location: 
Geisinger Medical Center Eye Institute Conference Room
Danville, PA 17822
United States
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation Credit
  • 1.00 COPE

Please login or register to take this course.